
Subtle Medical: Enhancing medical imaging efficiency and patient experience through innovative healthcare tech.
subtlemedical.comCrawled Oct 15, 2026
Blog Archive - Subtle Medical
Subtle Medical builds and delivers responsible AI solutions for the healthcare ecosystem.
Subtle Medical receives FDA clearance for SubtleHD(CT), its first CT product, which uses AI to reduce noise and improve low-contrast detectability across CT scanner generations. The clearance expands the company's image-enhancement portfolio, which already spans MRI and PET, and marks its eleventh FDA-cleared release.
Jun 2026 · PR NewswireNews article
Subtle Medical raises $33 million in growth capital through a Series C round led by funds managed by Morgan Stanley Expansion Capital. Returning backers also participate, while the company appoints Ohad Arazi CEO and moves co-founder Enhao Gong into the chief science officer role. It directs proceeds toward product development and global commercial expansion.
Jun 2026 · PR NewswireNews article
Subtle Medical receives FDA clearance for SubtleHD(PET), next-generation AI PET image enhancement software. It supports all FDA-approved radiotracers and enables substantially faster PET imaging on existing scanners. The clearance expands its reach to providers running theranostics programs and on-site cyclotrons.
May 2026 · PR NewswireNews article
Subtle Medical announced its participation in NVIDIA GTC 2026 in San Jose, where it presented two technical posters. The posters cover how SubtleHD-enhanced data improves downstream accuracy and a foundation model for MRI data standardization. The company also cites a long-standing NVIDIA partnership and its 2018 NVIDIA Inception Award in the healthcare category.
Mar 2026 · PR NewswireNews article